Mobile Clinic Services for Women Who Inject Drugs

N/A

Recruiting

Led By Maria Corcorran, MD, MPH

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will set up a pop-up clinic in a van near areas where women who inject drugs gather in north Seattle. The clinic will offer HIV prevention medication, opioid use disorder medication, and testing for

Who is the study for?

This trial is for women over 18 who inject drugs and are not known to have HIV. Participants must be willing to give informed consent, identify as female, and have a history of drug injection.

What is being tested?

The study tests the effectiveness of a mobile van clinic in increasing the use of HIV prevention medication (PrEP) and treatments for opioid addiction among women who inject drugs. It also evaluates on-site STI testing's impact on treatment completion rates.

What are the potential side effects?

Since this trial involves healthcare services rather than medications, there aren't typical side effects like with drugs. However, participants may experience discomfort or privacy concerns during testing or treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Evaluate uptake of PrEP and MOUD

Other study objectives

Assess acceptability of POC STI testing at community-based site

Assess acceptability of pilot community-based care model

Evaluate sustained use of PrEP and MOUD

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Study cohortExperimental Treatment1 Intervention

The investigators will enroll 50 female-identifying people who present to the clinical van for care and follow them for 6 months. The investigators will assess uptake of PrEP and buprenorphine; POC STI testing and treatment completion rates; sustained use of PrEP and buprenorphine at months 3 and 6 (n=50). The investigators will conduct surveys to assess and characterize the acceptability and feasibility of venue-based primary and HIV prevention care among women who inject drugs (WWID).

Do I qualify?Apply below to find out